191 related articles for article (PubMed ID: 12965910)
1. Molecular inflammatory responses measured in blood of patients with severe community-acquired pneumonia.
Fernández-Serrano S; Dorca J; Coromines M; Carratalà J; Gudiol F; Manresa F
Clin Diagn Lab Immunol; 2003 Sep; 10(5):813-20. PubMed ID: 12965910
[TBL] [Abstract][Full Text] [Related]
2. Expression Levels of Interferon Regulatory Factor 5 (IRF5) and Related Inflammatory Cytokines Associated with Severity, Prognosis, and Causative Pathogen in Patients with Community-Acquired Pneumonia.
Wang X; Guo J; Wang Y; Xiao Y; Wang L; Hua S
Med Sci Monit; 2018 May; 24():3620-3630. PubMed ID: 29847542
[TBL] [Abstract][Full Text] [Related]
3. Cytokine Concentrations in Plasma from Children with Severe and Non-Severe Community Acquired Pneumonia.
Haugen J; Chandyo RK; Brokstad KA; Mathisen M; Ulak M; Basnet S; Valentiner-Branth P; Strand TA
PLoS One; 2015; 10(9):e0138978. PubMed ID: 26407163
[TBL] [Abstract][Full Text] [Related]
4. Bacteremic pneumococcal pneumonia: clinical outcomes and preliminary results of inflammatory response.
Bordon JM; Fernandez-Botran R; Wiemken TL; Peyrani P; Uriarte SM; Arnold FW; Rodriquez-Hernandez L; Rane MJ; Kelley RR; Binford LE; Uppatla S; Cavallazzi R; Blasi F; Aliberti S; Restrepo MI; Fazeli S; Mathur A; Rahmani M; Ayesu K; Ramirez J
Infection; 2015 Dec; 43(6):729-38. PubMed ID: 26424683
[TBL] [Abstract][Full Text] [Related]
5. Cytokine expression in severe pneumonia: a bronchoalveolar lavage study.
Montón C; Torres A; El-Ebiary M; Filella X; Xaubet A; de la Bellacasa JP
Crit Care Med; 1999 Sep; 27(9):1745-53. PubMed ID: 10507593
[TBL] [Abstract][Full Text] [Related]
6. Systemic cytokine levels in community-acquired pneumonia and their association with disease severity.
Antunes G; Evans SA; Lordan JL; Frew AJ
Eur Respir J; 2002 Oct; 20(4):990-5. PubMed ID: 12412694
[TBL] [Abstract][Full Text] [Related]
7. Cytokine levels predict 30-day mortality in octogenarians and nonagenarians with community-acquired pneumonia: a retrospective observational study.
Pinargote-Celorio H; Miralles G; Cano M; Caparros E; Portilla J; González-Alcaide G; Ramos Rincón JM
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):299-307. PubMed ID: 31758443
[TBL] [Abstract][Full Text] [Related]
8. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia.
Menéndez R; Sahuquillo-Arce JM; Reyes S; Martínez R; Polverino E; Cillóniz C; Córdoba JG; Montull B; Torres A
Chest; 2012 Jun; 141(6):1537-1545. PubMed ID: 22194589
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone downregulates the systemic cytokine response in patients with community-acquired pneumonia.
Remmelts HH; Meijvis SC; Biesma DH; van Velzen-Blad H; Voorn GP; Grutters JC; Bos WJ; Rijkers GT
Clin Vaccine Immunol; 2012 Sep; 19(9):1532-8. PubMed ID: 22855392
[TBL] [Abstract][Full Text] [Related]
10. Phagocyte function and cytokine production in community acquired pneumonia.
Moussa K; Michie HJ; Cree IA; McCafferty AC; Winter JH; Dhillon DP; Stephens S; Brown RA
Thorax; 1994 Feb; 49(2):107-11. PubMed ID: 8128397
[TBL] [Abstract][Full Text] [Related]
11. Effects of age and comorbidities on serum levels of inflammatory markers in community-acquired pneumonia.
Viasus D; Simonetti AF; Estupiñan-Bohórquez AF; Carratalà J
Eur J Clin Invest; 2021 Jun; 51(6):e13480. PubMed ID: 33350464
[TBL] [Abstract][Full Text] [Related]
12. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response.
Tejera A; Santolaria F; Diez ML; Alemán-Valls MR; González-Reimers E; Martínez-Riera A; Milena-Abril A
Cytokine; 2007 Jun; 38(3):117-23. PubMed ID: 17659879
[TBL] [Abstract][Full Text] [Related]
13. Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia.
Paats MS; Bergen IM; Hanselaar WE; Groeninx van Zoelen EC; Hoogsteden HC; Hendriks RW; van der Eerden MM
Eur Respir J; 2013 Jun; 41(6):1378-85. PubMed ID: 23258791
[TBL] [Abstract][Full Text] [Related]
14. Systemic and bronchoalveolar cytokines as predictors of in-hospital mortality in severe community-acquired pneumonia.
Lee YL; Chen W; Chen LY; Chen CH; Lin YC; Liang SJ; Shih CM
J Crit Care; 2010 Mar; 25(1):176.e7-13. PubMed ID: 19592208
[TBL] [Abstract][Full Text] [Related]
15. Systemic cytokine profile in children with community-acquired pneumonia.
Michelow IC; Katz K; McCracken GH; Hardy RD
Pediatr Pulmonol; 2007 Jul; 42(7):640-5. PubMed ID: 17534977
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory responses in blood samples of human immunodeficiency virus-infected patients with pulmonary infections.
Benito N; Moreno A; Filella X; Miró JM; González J; Pumarola T; Valls ME; Luna M; García F; Rañó A; Torres A; Gatell JM
Clin Diagn Lab Immunol; 2004 May; 11(3):608-14. PubMed ID: 15138189
[TBL] [Abstract][Full Text] [Related]
17. Leucocyte response and anti-inflammatory cytokines in community acquired pneumonia.
Kolling UK; Hansen F; Braun J; Rink L; Katus HA; Dalhoff K
Thorax; 2001 Feb; 56(2):121-5. PubMed ID: 11209100
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia.
Ramírez P; Ferrer M; Martí V; Reyes S; Martínez R; Menéndez R; Ewig S; Torres A
Crit Care Med; 2011 Oct; 39(10):2211-7. PubMed ID: 21705887
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.
Ortqvist A; Hedlund J; Wretlind B; Carlström A; Kalin M
Scand J Infect Dis; 1995; 27(5):457-62. PubMed ID: 8588135
[TBL] [Abstract][Full Text] [Related]
20. Patterns of cytokine expression in community-acquired pneumonia.
Puren AJ; Feldman C; Savage N; Becker PJ; Smith C
Chest; 1995 May; 107(5):1342-9. PubMed ID: 7750329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
